Ikena Oncology Inc (IKNA) — Capital Reinvestment Ratio
Latest as of December 2019:
0.01x
Ikena Oncology Inc (IKNA) has a Capital Reinvestment Ratio of 0.01x as of December 2019, meaning it reinvests 0% of its operating cash flow ($47.93 Million) in capital expenditures ($316.00K). See cash generation quality of Ikena Oncology Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$47.93 Million
USD
Capital Expenditures
$316.00K
USD
Data as of
Dec 2019
Most recent filing
Ikena Oncology Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Ikena Oncology Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Ikena Oncology Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Ikena Oncology Inc from 2019 to 2019. For live market cap and broader valuation context, see IKNA stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.01x | $47.93 Million | $316.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow